N4 Pharma PLC
LSE:N4P

Watchlist Manager
N4 Pharma PLC Logo
N4 Pharma PLC
LSE:N4P
Watchlist
Price: 0.525 GBX Market Closed
Market Cap: 4.4m GBX

Net Margin
N4 Pharma PLC

-15 007%
Current
-15 892%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-15 007%
=
Net Income
-1.1m
/
Revenue
7.1k

Net Margin Across Competitors

Country Company Market Cap Net
Margin
UK
N4 Pharma PLC
LSE:N4P
4.4m GBP
-15 007%
US
Eli Lilly and Co
NYSE:LLY
1T USD
31%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
498.9B USD
27%
CH
Roche Holding AG
SIX:ROG
258.9B CHF
15%
UK
AstraZeneca PLC
LSE:AZN
211.4B GBP
16%
CH
Novartis AG
SIX:NOVN
208.6B CHF
26%
US
Merck & Co Inc
NYSE:MRK
260.5B USD
30%
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
33%
IE
Endo International PLC
LSE:0Y5F
209B USD
-126%
US
Pfizer Inc
NYSE:PFE
143.3B USD
16%
No Stocks Found

N4 Pharma PLC
Glance View

Market Cap
4.4m GBX
Industry
Pharmaceuticals

N4 Pharma Plc is a pharmaceutical company, which engages in the reformulation of existing drugs and vaccines. The company is headquartered in Derby, Derbyshire and currently employs 5 full-time employees. The company went IPO on 2005-06-07. The firm is engaged in engaged in the development of mesoparticulate silica delivery systems to improve the cellular delivery and potency of vaccines. The company is focused on developing a delivery system for vaccines and cancer treatments using its silica nanoparticle delivery system called Nuvec. Nuvec is a non-viral adjuvant delivery system that has the potential to revolutionize vaccines and cancer treatments. The company is focused on development and commercialization of medicines via its delivery system.

N4P Intrinsic Value
0.006 GBX
Overvaluation 99%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-15 007%
=
Net Income
-1.1m
/
Revenue
7.1k
What is the Net Margin of N4 Pharma PLC?

Based on N4 Pharma PLC's most recent financial statements, the company has Net Margin of -15 007%.

Back to Top